Cargando…
A gene mutation-based risk model for prognostic prediction in liver metastases
BACKGROUND: Liver metastasis is the major challenge in the treatment for malignant tumors. Genomic profiling is increasingly used in the diagnosis, treatment and prediction of prognosis in malignancies. In this study, we constructed a gene mutation-based risk model to predict the survival of liver m...
Autores principales: | Yu, Bingran, Zhang, Ning, Feng, Yun, Xu, Weiqi, Zhang, Ti, Wang, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463705/ https://www.ncbi.nlm.nih.gov/pubmed/37633919 http://dx.doi.org/10.1186/s12864-023-09595-9 |
Ejemplares similares
-
A population-based predictive model identifying optimal candidates for primary and metastasis resection in patients with colorectal cancer with liver metastatic
por: Jin, Xin, et al.
Publicado: (2022) -
Prognostic Models Incorporating RAS Mutation to Predict Survival in Patients with Colorectal Liver Metastases: A Narrative Review
por: Wong, Geoffrey Yuet Mun, et al.
Publicado: (2022) -
Risk and prognostic factors of breast cancer with liver metastases
por: Ji, Lei, et al.
Publicado: (2021) -
Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma
por: Yu, Bingran, et al.
Publicado: (2023) -
Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
por: Yu, Bingran, et al.
Publicado: (2023)